The decision comes as cases start to tick up again.
The Food and Drug Administration authorized a second booster dose of the Pfizer / BioNTech and Moderna COVID-19 vaccines for people over 50 or who are immunocompromised, the agencyThe decision comes as the United States heads into yet another wave of infections, this time driven by an even more transmissible version of the omicron variant of the virus.
The FDA said in aOnce again, the FDA isas the foundation for its decision-making around COVID-19 vaccines — in this case, data from Israel, which found a lower rate of serious illness and death in older adults who had two boosters compared with just one.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Covid-19: Two Covid-related deaths and 1,172 casesThe total number of deaths linked to Covid-19 in Northern Ireland since the start of the pandemic is 3,301.
Leer más »
Covid-19: Five Covid-related deaths and 1,204 casesThe total number of deaths linked to Covid-19 in Northern Ireland since the start of the pandemic is 3,306.
Leer más »
The FDA is expected to clear an additional COVID-19 booster shotThe FDA is poised to clear a fourth dose of the mRNA coronavirus vaccine for adults age 50 and older, looking to shore up protections for more vulnerable groups, a person familiar with the matter said.
Leer más »
FDA OKs second Pfizer, Moderna COVID-19 booster for ages 50 and upU.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.
Leer más »